68Ga-Pentixafor PET/CT Predicts Postoperative Outcomes in Primary Aldosteronism Surgery
Background
Primary aldosteronism (PA) is a leading cause of secondary hypertension, often requiring adrenalectomy for unilateral disease. Current diagnostic tools, including adrenal vein sampling (AVS), have limitations in lateralization accuracy. 68Ga-pentixafor PET/CT, targeting the chemokine receptor CXCR4, emerges as a novel functional imaging modality to address these gaps.
Study Design
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.